本計畫於民國78年度,由全省各縣市抽購國產及進口莫西林(Amoxicillin)口服膠囊製劑共50件,其中國產45件,進口5件。依據日本抗生物質醫藥品基準解說(MRAP)上所載之分光光度法及微生物法測定其力價,結果有5件未達合格標準,不合格率為10.0%。
In order to understand the potency of amoxicillin capsules, fifty samples (45 domestic, 5 imported) were purchased from different counties and cities in Taiwan during 1989 fiscal year. All of the samples were determined by the cylinder-plate method and optical method as described in the Minimum Requirements for Antibiotic Products of Japan. The results showed that 5 samples (10.0%) failed to meet the potency requirement of the government regulation (90-120%).